Global Actinic Keratosis Treatment Market Trends

Statistics for the 2023 & 2024 Global Actinic Keratosis Treatment market trends, created by Mordor Intelligence™ Industry Reports. Global Actinic Keratosis Treatment trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Trends of Global Actinic Keratosis Treatment Industry

This section covers the major market trends shaping the Actinic Keratosis Treatment Market according to our research experts:

Photodynamic Therapy Segment is Expected to Hold a Significant Market Share in the Actinic Keratosis Treatment Market

The photodynamic therapy segment holds a significant share of the actinic keratosis treatment market. It is anticipated to show a similar trend over the forecast period due to the noninvasive nature of the treatment, high target specificity, and a lower risk of scarring. The rising incidence of baldness, skin wrinkling, and sunburn patches have led to increased actinic keratosis cases. According to an article published by the National Library of Medicine in May 2022, countries closer to the equator demonstrate higher rates of actinic keratosis. The prevalence rates of actinic keratosis in Australia are close to 60% due to its proximity to the equator.

The recent initiatives, launches, and agreements by the market players are also aiding the market growth. For instance, in December 2022, Biofrontera AG's Scandinavian licensing partner Galenica AB, Malmö, Sweden, started the commercialization of Ameluz and BF-RhodoLED in Finland after Galenica had already successfully launched the Ameluz-photodynamic therapy in Sweden, Norway, and Denmark in mid-2021 under a licensing agreement at the end of 2020. Also, in December 2021, Biofrontera Inc. enrolled in a Phase 1 study to evaluate the safety and tolerability of photodynamic therapy (PDT) for the treatment of actinic keratosis (AK) using three tubes of Ameluz together with the company's BF-RhodoLED XL lamp. Such product approvals are expected to drive the market.

Actinic Keratosis Treatment Market : Daylight Photodynamic Therapy VS Conventional Photodynamic Therapy Treatment Response Rate for Actinic Keratosis, Australia, 2021

North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period

North America is expected to hold a significant share of the global actinic keratosis treatment market due to the growing prevalence of actinic keratosis coupled with a higher proportion of older individuals in this region. For instance, as per the 2021 America's Health Rankings data, over 54 million people over the age of 65 are living in the United States, comprising 16.5% of the total population. It was projected that the nation's total number of adults aged 65 and older will rise to an estimated 85.7 million by the year 2050. Furthermore, according to a Statistics Canada update, in April 2022, 1 in 5 Canadians (19%) were aged 65 and older (7 million), and approximately 25% were baby boomers (9.2 million) in 2021. Additionally, according to a World Bank update in January 2023, the population ages 65 and above in Mexico was reported at 8.13% in 2021. 

The recent initiatives, launches, and agreements by the market players are also aiding the market growth. For instance, in February 2021, Almirall launched its novel microtubule inhibitor, tirbanibulin (Klisyri, Almirall), for the topical treatment of actinic keratosis (AK) on the face and scalp in the United States. Such development is expected to drive the growth of the market.

Actinic Keratosis Treatment Market : Growth Rate by Region

Actinic Keratosis Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)